Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 23

1.

Is Every Patient Followed up as a Papillary Thyroid Cancer Patient Really That?

Abdulrezzak U, Tutus A, Kula M, Oztürk F, Soyuer I.

Mol Imaging Radionucl Ther. 2012 Apr;21(1):38-41. doi: 10.4274/Mirt.022866. Epub 2012 Apr 1.

3.

Fluorodeoxyglucose PET/CT in patients with differentiated thyroid cancer and elevated thyroglobulin after total thyroidectomy and (131)I ablation.

Salvatore B, Paone G, Klain M, Storto G, Nicolai E, D'Amico D, Della Morte AM, Pace L, Salvatore M.

Q J Nucl Med Mol Imaging. 2008 Mar;52(1):2-8.

4.

Clinical implication of F-18 FDG PET/CT for differentiated thyroid cancer in patients with negative diagnostic iodine-123 scan and elevated thyroglobulin.

Kim SJ, Lee TH, Kim IJ, Kim YK.

Eur J Radiol. 2009 Apr;70(1):17-24. doi: 10.1016/j.ejrad.2007.12.004. Epub 2008 Jan 18.

PMID:
18207685
6.

Combined metabolic and morphologic imaging in thyroid carcinoma patients with elevated serum thyroglobulin and negative cervical ultrasonography: role of 124I-PET/CT and FDG-PET.

Freudenberg LS, Antoch G, Frilling A, Jentzen W, Rosenbaum SJ, Kühl H, Bockisch A, Görges R.

Eur J Nucl Med Mol Imaging. 2008 May;35(5):950-7. doi: 10.1007/s00259-007-0634-8. Epub 2008 Jan 12.

PMID:
18193222
7.

Diagnostic value and therapeutic impact of (18)F-FDG-PET/CT in differentiated thyroid cancer. Results of a German multicentre study.

Riemann B, Uhrhan K, Dietlein M, Schmidt D, Kuwert T, Dorn R, Sciuk J, Kodalle T, Schober O.

Nuklearmedizin. 2013;52(1):1-6. doi: 10.3413/nukmed-0489-12-03. Epub 2012 Nov 28.

PMID:
23192295
8.

[Case of renal cell carcinoma with intertrabecular vertebral metastases detected f-18 fluorodeoxyglucose positron emission tomography and MRI].

Yoneyama S, Yumura Y, Koizumi M, Hanai T, Ishida H, Hattori Y, Teranishi J, Miyoshi Y, Kondo K, Noguchi K.

Hinyokika Kiyo. 2014 Jan;60(1):29-32. Japanese.

9.

Whole-body positron emission tomography using 18F-fluorodeoxyglucose compared to standard procedures for staging patients with Hodgkin's disease.

Jerusalem G, Beguin Y, Fassotte MF, Najjar F, Paulus P, Rigo P, Fillet G.

Haematologica. 2001 Mar;86(3):266-73.

10.

Comparison of ¹³¹I whole-body imaging, ¹³¹I SPECT/CT, and ¹⁸F-FDG PET/CT in the detection of metastatic thyroid cancer.

Oh JR, Byun BH, Hong SP, Chong A, Kim J, Yoo SW, Kang SR, Kim DY, Song HC, Bom HS, Min JJ.

Eur J Nucl Med Mol Imaging. 2011 Aug;38(8):1459-68. doi: 10.1007/s00259-011-1809-x. Epub 2011 Apr 20.

PMID:
21505897
11.

Late Recurrences of Thyroid Carcinoma 24 Years after a Complete Remission: When Monitoring Should be Stopped?

Nwatsock JF, Taïeb D, Zok FD, Mundler O.

World J Nucl Med. 2012 Jan;11(1):42-3. doi: 10.4103/1450-1147.98749.

12.

Metastatic colorectal cancer to a primary thyroid cancer.

Cherk MH, Moore M, Serpell J, Swain S, Topliss DJ.

World J Surg Oncol. 2008 Nov 11;6:122. doi: 10.1186/1477-7819-6-122.

13.

Robot-assisted Sistrunk's operation, total thyroidectomy, and neck dissection via a transaxillary and retroauricular (TARA) approach in papillary carcinoma arising in thyroglossal duct cyst and thyroid gland.

Byeon HK, Ban MJ, Lee JM, Ha JG, Kim ES, Koh YW, Choi EC.

Ann Surg Oncol. 2012 Dec;19(13):4259-61. doi: 10.1245/s10434-012-2674-y. Epub 2012 Oct 16.

PMID:
23070784
14.

F-18 FDG PET/CT in the management of thyroid cancer.

Iagaru A, Kalinyak JE, McDougall IR.

Clin Nucl Med. 2007 Sep;32(9):690-5.

PMID:
17710020
15.

Is there a role for fluorodeoxyglucose positron emission tomography/computed tomography in cytologically indeterminate thyroid nodules?

Hales NW, Krempl GA, Medina JE.

Am J Otolaryngol. 2008 Mar-Apr;29(2):113-8. doi: 10.1016/j.amjoto.2007.04.006.

PMID:
18314022
16.

Histopathologic characterization of radioactive iodine-refractory fluorodeoxyglucose-positron emission tomography-positive thyroid carcinoma.

Rivera M, Ghossein RA, Schoder H, Gomez D, Larson SM, Tuttle RM.

Cancer. 2008 Jul 1;113(1):48-56. doi: 10.1002/cncr.23515.

17.

Simultaneous occurrence of distant metastases to the small intestine and the thoracic esophagus from anaplastic thyroid carcinoma: a case report.

Kobayashi M, Itabashi H, Ikeda T, Yamazaki N, Kaji T, Takagane A.

Surg Case Rep. 2015;1(1):63. doi: 10.1186/s40792-015-0066-9. Epub 2015 Aug 12.

18.

Thyroid Mass: Metastasis from Nasopharyngeal Cancer - An Unusual Presentation.

Lewis SC, D'cruz AK, Joshi A, Kumar R, Kane SV, Laskar SG.

Indian J Palliat Care. 2017 Jan-Mar;23(1):104-108. doi: 10.4103/0973-1075.197951.

19.

Paraneoplastic pemphigus as a first sign of metastatic retroperitoneal inflammatory myofibroblastic tumor: (18)F-FDG PET/CT findings.

Dhull VS, Passah A, Rana N, Arora S, Mallick S, Kumar R.

Rev Esp Med Nucl Imagen Mol. 2016 Jul-Aug;35(4):260-2. doi: 10.1016/j.remn.2015.09.005. Epub 2015 Dec 28. English, Spanish.

20.

Papillary Thyroid Carcinoma Metastases Presenting as Ipsilateral Adrenal Mass and Renal Cyst.

Ginzburg S, Reddy M, Veloski C, Sigurdson E, Ridge JA, Azrilevich M, Kutikov A.

Urol Case Rep. 2015 Sep 16;3(6):221-2. doi: 10.1016/j.eucr.2015.08.007. eCollection 2015 Nov.

Supplemental Content

Support Center